Schizophrenia News

High-potency cannabis use appeared associated with mental health and addiction, according to results of a cohort study published in JAMA Psychiatry.

Quetiapine may need a new black box warning because of its association with prolonged and sometimes painful erections known as priapism, according to data presented at the American Society of Clinical Psychopharmacology Annual Meeting.

Aristada Initio and Invega Sustenna appeared well tolerated and effective for initiating in-hospital schizophrenia treatment and continuing outpatient treatment, according to a study published in Journal of Clinical Psychiatry.

A combination of olanzapine and samidorphan was well tolerated and not associated with new safety risks compared with olanzapine alone, according to data presented during the Virtual 2020 Schizophrenia International Research Society Congress.

Ketamine appeared associated with psychosis-like symptoms among healthy individuals, according to results of a systematic review and meta-analysis published in JAMA Network Open.

Researchers have observed significant changes in the treatment of bipolar disorder over the past 2 decades, according to study results published in American Journal of Psychiatry.

Individuals who recover from COVID-19 infection may experience a significant neuropsychiatric burden long after the current pandemic, according to authors of a review article published in Brain, Behavior, and Immunity. Thus, researchers should conduct prospective neuropsychiatric and neuroimmune monitoring of those exposed to SARS-CoV-2 at various points in the life course to better understand the long-term impact of COVID-19, as well as to create a framework for the integration of psychoneuroimmunology into epidemiologic studies of pandemics, the authors noted.

Researchers have uncovered several prenatal and perinatal factors associated with later psychosis onset, according to results of a systematic review and meta-analysis published in The Lancet Psychiatry.

Patients with schizophrenia and alcohol use disorder experienced a worse illness course than those with only schizophrenia, according to results of a post hoc analysis published in Journal of Clinical Psychiatry.

Clinicians should frequently monitor metabolic traits during early stages of antipsychotic treatment because of rapid and substantial changes that can occur, according to results of a randomized, open-label, pharmacologic trial published in Journal of Clinical Psychiatry.